HCW Biologics (NASDAQ:HCWB) Stock to Reverse Split on Friday, April 11th

Shares of HCW Biologics Inc. (NASDAQ:HCWB) are scheduled to reverse split on the morning of Friday, April 11th. The 1-40 reverse split was announced on Tuesday, April 1st. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, April 10th.

HCW Biologics Stock Performance

Shares of HCW Biologics stock opened at $0.28 on Thursday. The firm has a market cap of $12.55 million, a PE ratio of -0.28 and a beta of 0.71. HCW Biologics has a 1 year low of $0.21 and a 1 year high of $2.52. The firm’s 50-day simple moving average is $0.36 and its 200-day simple moving average is $0.44.

HCW Biologics (NASDAQ:HCWB) last announced its quarterly earnings data on Friday, March 28th. The company reported ($0.08) earnings per share for the quarter. HCW Biologics had a negative net margin of 1,067.82% and a negative return on equity of 2,516.84%. The firm had revenue of $0.40 million during the quarter.

HCW Biologics Company Profile

HCW Biologics Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases.